Intercept Pharmaceuticals Announces Proposed Offerings of $200 Million of Common Stock and $200 Million of Convertible Senior Notes due 2026

World News: . []

NEW YORK May 08 2019 GLOBE NEWSWIRE -- Intercept Pharmaceuticals IncNasdaqICPT a biopharmaceutical LINK  focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver LINK  today anno unced t...

More news and information about Intercept Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:05 GMT Wednesday 8th May 2019

Published: .

Search for other references to "intercept" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us